Success Story: Reproductive Biotechnology Expert Secures NIW Approval Thanks To Our Expert Filing
Client’s Testimonial:
“I appreciate the support that your team provided during the preparation of my I-140 petition.”
On October 1st, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Embryology Researcher in the Field of Reproductive Biotechnology (Approval Notice).
General Field: Reproductive Biotechnology
Position at the Time of Case Filing: Embryology Researcher
Country of Origin: Indonesia
Country of Residence at the Time of Filing: Australia
Approval Notice Date: October 1st, 2026
Processing Time: 16 months, 23 days (Premium Processing Upgrade Requested)
Case Summary:
Our client, a reproductive biotechnology expert holding a Ph.D. in agricultural sciences, has built his research around this critical healthcare challenge. His work broadly focuses on improving the safety and efficacy of assisted reproductive technologies (ARTs) by targeting cellular quality, metabolic function, and early embryonic development.
Rather than focusing only on the highly technical details of individual cellular analyses, we demonstrated how this broader research direction could contribute to overcoming severe barriers to natural conception, mitigating the impacts of medical and genetic challenges, and supporting healthier pregnancies. We further connected these goals to U.S. priorities involving public health, reproductive equity, and the national effort to reduce infertility rates.
Turning Research Experience into Evidence of Future Potential
His scholarly record included 22 peer-reviewed journal articles (including 8 first- or co-first-authored papers) and 5 scientific abstracts. His published work had also accumulated 676 citations, while he had completed at least 10 peer reviews for scholarly publications.
Demonstrating Influence Beyond the Numbers
We did not present these metrics as sufficient on their own. Instead, we explained what they revealed about the client's standing and influence. Several of his publications had citation rates placing them among highly cited molecular biology and genetics papers from their respective publication years, including one paper in the top 1% and several others within the top 10% and 20%. This comparison helped show that researchers were engaging with his findings at rates exceeding typical citation patterns for comparable work.
We also documented examples of independent researchers using the client's prior work to inform subsequent studies. Independent teams relied on his findings regarding maternal dietary impacts, age-related fertility interventions, and gene regulatory networks to advance their own clinical models of female reproductive health. Combined with his peer-review activity, these examples supported a broader pattern of scholarly reliance and professional trust, strengthening the argument that his research had already contributed meaningfully to reproductive biotechnology and that he possessed the expertise necessary to advance his proposed work.
A Successful NIW Outcome
By connecting the client's technical background, publication record, independent research influence, and future plans to broader U.S. needs, we presented a cohesive case for both the national importance of his endeavor and his ability to advance it. His I-140 NIW petition was approved, allowing him to continue pursuing research aimed at supporting the next generation of assisted reproductive therapies.
We congratulate the client on this achievement and wish him continued success as he advances his work in reproductive biotechnology.